Guardion Health Sciences, Inc.

GHSICIK 0001642375 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 29, 2024. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone 0.0019

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Dec 26, 20245.02 · Departure/Election8.01 · Other Events9.01 · Financial Statements and Exhibits Nov 18, 2024no items parsed Oct 31, 2024no items parsed Oct 3, 2024no items parsed Sep 23, 2024no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Guardion Health Sciences, Inc.

Name	Roles	Filings
Gagliano Donald A	Director	2
Goldstone Mark	Director	2
Griggs Michaela	Director	2
Radoff Bradley Louis	10% Owner	2
Radoff Family Foundation	-	2

Showing 1-5 of 8

Per pagePage 1 of 2Next

All filings

13 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Jun 21, 2022	Griggs Michaela Director	Holdings only	-	-	-
Jun 16, 2022	Scholtes Bret CEO and President · Director	FTax	37,175	$0.65	$24,164
Mar 3, 2022	Scholtes Bret CEO and President · Director	AGrant	152,671	-	-

Showing 11-13 of 13

Per pagePrevPage 3 of 3

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value